• The Impact of Coupons and Co-Pay Assistance on Adherence

    Prescription Costs Impact Medication Adherence
    A $10 change in cost to patients results in a 3.8% drop in adherence. 85% of studies demonstrated a statistically significant relationship between increased patient cost sharing and decreased medication adherence.1

    Patients struggling to afford medications may not be adherent
    22% of non-adherent patients said "trying to save money" was a major reason for not filling a prescription.2

    Affordability impacts prescription fill rates
    In a September 2016 study, 80% of prescribers agreed that co-pay coupons are an effective affordability tool, encouraging patients to fill their first prescription.3

    The link between affordability and adherence extends to outcomes
    In a major literature review, 19 of 25 studies (76%) indicated that increased patient cost sharing adversely affected clinical outcomes across a variety of disease states.4
    How to Improve Medication Adherence

    ConnectiveRx combines the market-leading expertise of PSKW with the trust and impact of PDR®, publishers of the Physicians' Desk Reference®, to deliver the affordability programs that make a difference in patients' lives.
    Put active coupon and co-pay programs into the hands of patients as they leave the office, clinic or hospital.
    Integrated within e-prescribing workflow, when a financial offer is associated with the medication prescribed the prescriber will see a notification on the screen.

    A printed handout is generated, as well as an e-script that includes adjudication information in the Notes field to alert the pharmacist that a savings offer is available.

    Patients may take their personalized eCopay® handout to their pharmacy for immediate use.
    Motivate patients to fill their prescriptions, start and stay on therapies, in real time.
    When an e-prescription is written during a medical encounter, a personalized ScriptGuide® is generated from within EMR workflow.

    These handouts may include details about financial assistance programs for the medications prescribed, educational information about diagnoses, and more.

    To learn more about these tools, contact us today.

    1. Eaddy MT, Cook CL, O’Day K, Burch SP, et al. How Patient Cost Sharing Affects Adherence and Outcomes/p50/colB/¶5. From http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278192. Accessed 10/09/14. Expected impact estimated from linear regression model based on studies in review. Impact varies depending on population and intervention affected. In the literature review, 66 abstracts assessed the impact of patient cost sharing and medication adherence. Treatment or disease areas in study included cardiovascular, diabetes, mental health, pulmonary, arthritis, infectious disease and GI disease.
    2. "Medication Adherence in America, A National Report Card," National Community Pharmacists Association. Based on a survey of 1,020 adults taking chronic medications.
    3. ConnectiveRx Co-Pay Prescriber Survey, August 2016, n=398 prescribers (MDs, DOs, NPs, PAs) from the ConnectiveRx Proprietary HCP Database, as well as practice office staff responsible for co-pay coupons.
    4. Eaddy MT, Cook, CL, O’Day K et al., "How Patient Cost-Sharing Trends Affect Adherence and Outcomes: A Literature Review," P&T, Vol. 37, #1, January 2012.